In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study / BONIFAZI F.; BANDINI G.; STANZANI M.; PALANDRI F.; GIANNINI B.; ARPINATI M.; ROSTI G.; BACCARANI M.. - In: BONE MARROW TRANSPLANTATION. - ISSN 0268-3369. - STAMPA. - 35:(2005), pp. 1025-1026. [10.1038/sj.bmt.1704940]
In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study.
BONIFAZI, FRANCESCA;BANDINI, GIUSEPPE;STANZANI, MARTA;PALANDRI, FRANCESCA;ARPINATI, MARIO;ROSTI, GIANANTONIO;BACCARANI, MICHELE
2005
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.